Texas Enterosorbents Incorporated

Quick facts

Phase 2 pipeline

• ACCS100
  ACCS100 is an investigational drug that works by binding to and inhibiting the activity of a specific molecular target.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Texas Enterosorbents Incorporated portfolio CI brief
• Texas Enterosorbents Incorporated pipeline updates RSS